Search Within

Laure Michaud

Formats
  1. Journal Article (17)
  2. Meeting Abstract (16)
  3. Book Section (1)
Groups
  1. Sloan Kettering Institute Postdocs (34)
  2. Molecular Imaging and Therapy Service (32)
  3. Radiology, Department of (32)
  4. Department of Medicine (23)
  5. Hematologic Malignancies, Division of (19)
  6. Center for Hematologic Malignancies (18)

More Groups

People
  1. Heiko Schoder (29)
  2. Reiko Nakajima (12)
  3. Audrey Mauguen (11)
  4. Connie Batlevi (10)
  5. Gilles Salles (10)
  6. Alison Moskowitz (9)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (9)

More Years

Publications
  1. Journal of Nuclear Medicine (9)
  2. Blood (6)
  3. European Journal of Nuclear Medicine and Molecular Imaging (4)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Actas Urológicas Españolas (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (9)
  2. American Society of Hematology (7)
  3. Springer (5)
  4. Elsevier Inc. (4)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (34)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of (18)F-fluoromisonidazole hypoxia PET/CT diagnostic interpretation criteria and validation of interreader reliability, reproducibility, and performance
    Journal Article

    Wray, R.; Mauguen, A.; Michaud, L.; Leithner, D.; Yeh, R.; Riaz, N.; Mirtcheva, R.; Sherman, E.; Wong, R.; Humm, J.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Prognostic value of (18)F-FDG PET/CT in diffuse large B-cell lymphoma treated with a risk-adapted immunochemotherapy regimen
    Journal Article

    Michaud, L.; Bantilan, K.; Mauguen, A.; Moskowitz, C. H.; Zelenetz, A. D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Interim positron emission tomography during frontline chemoimmunotherapy for follicular lymphoma
    Journal Article

    Merryman, R. W.; Michaud, L.; Redd, R.; Mondello, P.; Park, H.; Spilberg, G.; Robertson, M.; Taranto, E.; Ahmed, G.; Chase, M.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Teaching cases in nuclear oncology: Lymphomas
    Book Section

    Ito, K.; Gavane, S.; Michaud, L.; Schöder, H.; Yerubaudi, V.; Sakellis, C. G.; Van den Abbeele, A. D.; Jacene, H. A.; Al Shammari, S.; Fraioli, F.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save